Browsing by Author Noluthando Mwelase

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
26-Feb-2015C-Reactive Protein (CRP), interferon gamma-inducible protein 10 (IP-10), and lipopolysaccharide (LPS) are associated with risk of tuberculosis after initiation of antiretroviral therapy in resource-limited settingsMark W. Tenforde; Nikhil Gupte; David W. Dowdy; David M. Asmuth; Ashwin Balagopal; Richard B. Pollard; Patcharaphan Sugandhavesa; Javier R. Lama; Sandy Pillay; Sandra W. Cardoso; Jyoti Pawar; Breno Santos; Cynthia Riviere; Noluthando Mwelase; Cecilia Kanyama; Johnstone Kumwenda; James G. Hakim; Nagalingeswaran Kumarasamy; Robert Bollinger; Richard D. Semba; Thomas B. Campbell; Amita Gupta
14-Mar-2019One month of rifapentine plus isoniazid to prevent HIV-related TuberculosisSusan Swindells; Ritesh Ramchandani; Amita Gupta; Constance A. Benson; Jorge Leon-Cruz; Noluthando Mwelase; Marc A. Jean Juste; Javier R. Lama; Javier Valencia; Ayotunde Omoz-Oarhe; Khuanchai Supparatpinyo; Gaerolwe Masheto; Lerato Mohapi; Rodrigo O. Da Silva Escada; Sajeeda Mawlana; Peter Banda; Patrice Severe; James Hakim; Cecilia Kanyama; Deborah Langat; Laura Moran; Janet Andersen; Courtney V. Fletcher; Eric Nuermberger; Richard E. Chaisson
1-Jan-2020Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapineDavid W. Haas; Anthony T. Podany; Yajing Bao; Susan Swindells; Richard E. Chaisson; Noluthando Mwelase; Khuanchai Supparatpinyo; Lerato Mohapi; Amita Gupta; Constance A. Benson; Paxton Baker; Courtney V. Fletcher
1-Sep-2022Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based DosingMichelle M. Pham; Anthony T. Podany; Noluthando Mwelase; Khuanchai Supparatpinyo; Lerato Mohapi; Amita Gupta; Wadzanai Samaneka; Ayotunde Omoz-Oarhe; Deborah Langat; Constance A. Benson; Richard E. Chaisson; Susan Swindells; Courtney V. Fletcher
4-May-2017Virologic outcomes in early antiretroviral treatment: HPTN 052Susan H. Eshleman; Ethan A. Wilson; Xinyi C. Zhang; San San Ou; Estelle Piwowar-Manning; Joseph J. Eron; Marybeth McCauley; Theresa Gamble; Joel E. Gallant; Mina C. Hosseinipour; Nagalingeswaran Kumarasamy; James G. Hakim; Ben Kalonga; Jose H. Pilotto; Beatriz Grinsztejn; Sheela V. Godbole; Nuntisa Chotirosniramit; Breno Riegel Santos; Emily Shava; Lisa A. Mills; Ravindre Panchia; Noluthando Mwelase; Kenneth H. Mayer; Ying Q. Chen; Myron S. Cohen; Jessica M. Fogel